Prediction of the 1-Year Risk of Incident Lung Cancer: Prospective Study Using Electronic Health Records from the State of Maine

Abstract

Background Lung cancer is the leading cause of cancer death worldwide. Early detection of individuals at risk of lung cancer is critical to reduce the mortality rate. Objective The aim of this study was to develop and validate a prospective risk prediction model to identify patients at risk of new incident lung cancer within the next 1 year in the general population. Methods Data from individual patient electronic health records (EHRs) were extracted from the Maine Health Information Exchange network. The study population consisted of patients with at least one EHR between April 1, 2016, and March 31, 2018, who had no history of lung cancer. A retrospective cohort (N=873,598) and a prospective cohort (N=836,659) were formed for model construction and validation. An Extreme Gradient Boosting (XGBoost) algorithm was adopted to build the model. It assigned a score to each individual to quantify the probability of a new incident lung cancer diagnosis from October 1, 2016, to September 31, 2017. The model was trained with the clinical profile in the retrospective cohort from the preceding 6 months and validated with the prospective cohort to predict the risk of incident lung cancer from April 1, 2017, to March 31, 2018. Results The model had an area under the curve (AUC) of 0.881 (95% CI 0.873-0.889) in the prospective cohort. Two thresholds of 0.0045 and 0.01 were applied to the predictive scores to stratify the population into low-, medium-, and high-risk categories. The incidence of lung cancer in the high-risk category (579/53,922, 1.07%) was 7.7 times higher than that in the overall cohort (1167/836,659, 0.14%). Age, a history of pulmonary diseases and other chronic diseases, medications for mental disorders, and social disparities were found to be associated with new incident lung cancer. Conclusions We retrospectively developed and prospectively validated an accurate risk prediction model of new incident lung cancer occurring in the next 1 year. Through statistical learning from the statewide EHR data in the preceding 6 months, our model was able to identify statewide high-risk patients, which will benefit the population health through establishment of preventive interventions or more intensive surveillance.

Recurrence of SARS-CoV-2 PCR positivity in COVID-19 patients: a single center experience and potential implications

“…Univariable analysis was performed on z-score-normalized features, and logistic regression was used to calculate the odds ratios and P values for feature filtering. For multivariate model building, a gradient boosting tree algorithm XGBoost was used for constructing a multivariable prediction model [10][11][12][13][14][15][16] . The baseline learner is the classification and regression tree and the number of trees is selected via cross-validation to avoid over-fitting.…”

Leveraging Genetic Reports and Electronic Health Records for the Prediction of Primary Cancers: Algorithm Development and Validation Study

“…The overall AUROC was 77.3%, where AUROCs of 88.7% for cancer of rectum and anus, 88.6% for cancer of the liver and intrahepatic bile duct, 85.9% for cancer of the prostate were predicted with a time interval of 12 months. Multiple studies have utilized electronic health record data to predict specific cancers, where AUROCs of 88.1% for lung cancer [ 88 ], 64.8% for breast cancer [ 89 ], 85% for pancreatic cancer [ 90 ] were achieved, and 85.7% precision and 60.0% recall were achieved for colorectal cancer [ 91 ]. Our method achieved AUROC 96.56% in general and outperformed the state-of-the-art methods for most cancer types.…”

Early detection of prostate gland and breast cancer risk based on routine check-up data using survival analysis trees for left-truncated and right-censored data

“…Another approach aims to develop new cancer risk prediction tools based on historical medical records of patients, collected as part of routine care in Electronic Medical Records (EMR). Such models were suggested for lung cancer [18], colorectal cancer [19], and Acute Myeloid Leukemia [20], among others. Moreover, advanced genetic methods are also employed for screening, mostly using polygenic risk scores [21].…”